Fort Washington Investment Advisors’s AstraZeneca AZN Stock Holding History

Fort Washington Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,770	Closed	-$367K	–	385
2015 Q3	$367K	Hold	5,770	–	–	0.01%	391
2015 Q2	$368K	Hold	5,770	–	–	0.01%	362
2015 Q1	$395K	Sell	5,770 -239	-4%	-$16.6K	0.01%	355
2014 Q4	$423K	Hold	6,009	–	–	0.01%	349
2014 Q3	$429K	Hold	6,009	–	–	0.01%	354
2014 Q2	$447K	Hold	6,009	–	–	0.01%	356
2014 Q1	$390K	Hold	6,009	–	–	0.01%	359
2013 Q4	$357K	Hold	6,009	–	–	0.01%	427
2013 Q3	$312K	Sell	6,009 -468	-7%	-$23.5K	0.01%	395
2013 Q2	$306K	Buy	+6,477	New	+$330K	0.01%	386

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Fort Washington Investment Advisors's AZN Position: Q4 2015 in Review

Fort Washington Investment Advisors sold out of AstraZeneca (AZN) in Q4 2015, closing a stake of 5,770 shares — an estimated $367K sold.

Fort Washington Investment Advisors first reported a position in AZN in Q2 2013 and held it in 10 quarters. The position peaked at $447K in Q2 2014. 390 funds tracked by Wall St. Rank hold AZN as of Q4 2015.

Fort Washington Investment Advisors reported no remaining AstraZeneca position as of Q4 2015 after selling out during the quarter.
Fort Washington Investment Advisors sold 5,770 AstraZeneca shares in Q4 2015, an estimated $367K.
Fort Washington Investment Advisors first reported a position in AstraZeneca in Q2 2013 and held it in 10 quarters.
Fort Washington Investment Advisors's AstraZeneca position peaked at $447K in Q2 2014.
390 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2015.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.